Journal article
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.
- Abstract:
-
BACKGROUND: Daily aspirin reduces the long-term incidence of some adenocarcinomas, but effects on mortality due to some cancers appear after only a few years, suggesting that it might also reduce growth or metastasis. We established the frequency of distant metastasis in patients who developed cancer during trials of daily aspirin versus control. METHODS: Our analysis included all five large randomised trials of daily aspirin (≥75 mg daily) versus control for the prevention of vascular events...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Lancet
- Volume:
- 379
- Issue:
- 9826
- Pages:
- 1591-1601
- Publication date:
- 2012-04-01
- DOI:
- EISSN:
-
1474-547X
- ISSN:
-
0140-6736
- Source identifiers:
-
320385
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:320385
- UUID:
-
uuid:a3871e28-0e89-4c27-994c-15ff5c40e8a0
- Local pid:
- pubs:320385
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2012
If you are the owner of this record, you can report an update to it here: Report update to this record